How Can Immunotherapy Be Guided by Cancer Characterization?
Cancer characterization can identify specific antigens or immune checkpoints that can be targeted by immunotherapy. For instance, PD-L1 expression levels can determine the likelihood of response to checkpoint inhibitors like pembrolizumab.